Format

Send to

Choose Destination
PET Clin. 2019 Jan;14(1):81-89. doi: 10.1016/j.cpet.2018.08.013. Epub 2018 Oct 24.

PET Imaging of Peripheral Nerve Tumors.

Author information

1
Department of Molecular Imaging and Radionuclide Therapy (MIRT), The Persian Gulf Nuclear Medicine Research Center, Bushehr Medical University Hospital, Bushehr University of Medical Sciences, Moallem Street, Bushehr 3631, Iran.
2
Department of Diagnostic Radiology, Keck School of Medicine, University of Southern California (USC), 1520 San Pablo Street, Suite L1600, Los Angeles, CA 90033, USA.
3
Department of Cardiology, Tehran Medical Unit, Azad University, Shariati Street, Tehran 1916893813, Iran.
4
Department of Diagnostic Radiology, Keck School of Medicine, University of Southern California (USC), 1520 San Pablo Street, Suite L1600, Los Angeles, CA 90033, USA. Electronic address: gholamre@med.usc.edu.

Abstract

PET has been founded as a useful technique in the staging, restaging, prognostication, and treatment planning for numerus cancers, with an incremental application in precision oncology. This paper summarized the current state-of-the-art application of PET/CT in the management of patients with peripheral nerve tumors. Furthermore, the potential clinical uses of emerging themes and technological advances are reviewed, consisting hybrid PET/MR imaging and alternative radiotracers for the application in peripheral nerve oncology.

KEYWORDS:

Malignant peripheral nerve sheath tumor (MPSNT); PET; PET/CT imaging; PET/MR imaging

PMID:
30420224
DOI:
10.1016/j.cpet.2018.08.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center